Inclusion Criteria:  Patients aged 19 years and older Patients with T2DM eligible for treatment with Qtern as indicated in the locally approved prescribing information Patients with evidence of a personally signed and dated informed consent document indicating that the patient (or a legally acceptable representative) has been informed of all pertinent aspects of the study.  Exclusion Criteria:  Patients treated with Qtern outside of the locally approved Prescription Information in Korea Patients with contraindications for the use of Qtern (as described in the Korean Prescription Information)